Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benigno Rodriguez

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
AIDS (London, England)|May 9, 2009
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performanceChristina M Marra, Yu Zhao, David B Clifford, et al.
Blood|October 16, 2012
Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndromeNicholas T Funderburg, David A Zidar, Carey Shive, et al.
The Journal of Infectious Diseases|July 12, 2012
Baseline levels of soluble CD14 and CD16+56- natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfectionDonald D Anthony, Sara J Conry, Kathy Medvik, et al.
Science Advances|December 19, 2025
Interleukin-2 is a potent latency reversal agent in people with treated HIV-1Michael L Freeman, Brian M Clagett, Konstantin Leskov, et al.
AIDS (London, England)|December 15, 2010
Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical careHeidi M Crane, Carl Grunfeld, James H Willig, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211Timothy J Wilkin, Zhaohui Su, Daniel R Kuritzkes, et al.
Blood|October 16, 2009
Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activationNicholas T Funderburg, Elizabeth Mayne, Scott F Sieg, et al.
Journal of Clinical Microbiology|June 27, 2014
Identification of occult Fusobacterium nucleatum central nervous system infection by use of PCR-electrospray ionization mass spectrometrySudha Nagalingam, Michelle Lisgaris, Benigno Rodriguez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2012
Characterizing HIV transmission networks across the United StatesJeannette L Aldous, Sergei Kosakovsky Pond, Art Poon, et al.
AIDS and Behavior|October 29, 2018
Physical Activity Intensity is Associated with Symptom Distress in the CNICS CohortAllison R Webel, Amanda L Willig, Wei Liu, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
AIDS (London, England)|May 9, 2009
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performanceChristina M Marra, Yu Zhao, David B Clifford, et al.
Blood|October 16, 2012
Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndromeNicholas T Funderburg, David A Zidar, Carey Shive, et al.
The Journal of Infectious Diseases|July 12, 2012
Baseline levels of soluble CD14 and CD16+56- natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfectionDonald D Anthony, Sara J Conry, Kathy Medvik, et al.
Science Advances|December 19, 2025
Interleukin-2 is a potent latency reversal agent in people with treated HIV-1Michael L Freeman, Brian M Clagett, Konstantin Leskov, et al.
AIDS (London, England)|December 15, 2010
Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical careHeidi M Crane, Carl Grunfeld, James H Willig, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211Timothy J Wilkin, Zhaohui Su, Daniel R Kuritzkes, et al.
Blood|October 16, 2009
Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activationNicholas T Funderburg, Elizabeth Mayne, Scott F Sieg, et al.
Journal of Clinical Microbiology|June 27, 2014
Identification of occult Fusobacterium nucleatum central nervous system infection by use of PCR-electrospray ionization mass spectrometrySudha Nagalingam, Michelle Lisgaris, Benigno Rodriguez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2012
Characterizing HIV transmission networks across the United StatesJeannette L Aldous, Sergei Kosakovsky Pond, Art Poon, et al.
AIDS and Behavior|October 29, 2018
Physical Activity Intensity is Associated with Symptom Distress in the CNICS CohortAllison R Webel, Amanda L Willig, Wei Liu, et al.
Pageof 14